SE7612960L - Tienamycinderivat - Google Patents

Tienamycinderivat

Info

Publication number
SE7612960L
SE7612960L SE7612960A SE7612960A SE7612960L SE 7612960 L SE7612960 L SE 7612960L SE 7612960 A SE7612960 A SE 7612960A SE 7612960 A SE7612960 A SE 7612960A SE 7612960 L SE7612960 L SE 7612960L
Authority
SE
Sweden
Prior art keywords
hydrogen
pharmaceutically acceptable
acceptable salts
acyl
derivatives
Prior art date
Application number
SE7612960A
Other languages
English (en)
Other versions
SE427840B (sv
Inventor
L Barash
B G Christensen
W J Leanza
J Hannah
D H-M Shih
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7612960L publication Critical patent/SE7612960L/sv
Publication of SE427840B publication Critical patent/SE427840B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7612960A 1975-11-21 1976-11-19 Analogiforfarande for framstellning av tienamycinderivat SE427840B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63429175A 1975-11-21 1975-11-21

Publications (2)

Publication Number Publication Date
SE7612960L true SE7612960L (sv) 1977-05-22
SE427840B SE427840B (sv) 1983-05-09

Family

ID=24543192

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612960A SE427840B (sv) 1975-11-21 1976-11-19 Analogiforfarande for framstellning av tienamycinderivat

Country Status (8)

Country Link
JP (1) JPS5277083A (sv)
CH (1) CH632509A5 (sv)
DE (1) DE2652675A1 (sv)
DK (1) DK523276A (sv)
FR (1) FR2332016A1 (sv)
GB (1) GB1570986A (sv)
NL (1) NL189298C (sv)
SE (1) SE427840B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008888B1 (en) * 1978-08-23 1983-09-21 Beecham Group Plc Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them
DK456580A (da) * 1979-10-29 1981-06-04 Beecham Group Ltd Fremgangsmaade til fremstilling af bicycliske beta-lactamringholdige forbindelser
EP0044142A1 (en) * 1980-07-03 1982-01-20 Beecham Group Plc Process for the preparation of beta-lactam antibiotics
US10695322B2 (en) 2016-01-29 2020-06-30 The Johns Hopkins University Inhibitors of bacterial growth

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1004670A (en) * 1963-04-23 1965-09-15 Beecham Res Lab Penicillins
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds

Also Published As

Publication number Publication date
DE2652675C2 (sv) 1990-02-01
JPS5277083A (en) 1977-06-29
JPS61346B2 (sv) 1986-01-08
NL189298B (nl) 1992-10-01
CH632509A5 (en) 1982-10-15
FR2332016A1 (fr) 1977-06-17
GB1570986A (en) 1980-07-09
FR2332016B1 (sv) 1978-11-10
DK523276A (da) 1977-05-22
NL189298C (nl) 1993-03-01
SE427840B (sv) 1983-05-09
DE2652675A1 (de) 1977-06-02
NL7612940A (nl) 1977-05-24

Similar Documents

Publication Publication Date Title
IE792028L (en) Pyrroloazetidinones
ES469425A1 (es) Un procedimiento para la preparacion de derivados de tiena- micina
GB1530201A (en) Process for the preparation of aminoglycoside antibiotics and intermediates therefor
SE7612960L (sv) Tienamycinderivat
ES476154A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina
ES458557A1 (es) Un procedimiento de preparacion de derivados de quinazolina.
SE7612962L (sv) Tienamycinderivat
SE7607088L (sv) 5-fluor-uracilderivat.
ZA911815B (en) Fluorobenzenesulfonamides
ES450897A1 (es) Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-noroximorfona.
GB1471847A (en) Dibenzofuran derivatives
SE7612961L (sv) Tienamycinderivat
SE7612295L (sv) Antibiotikum
GB1547473A (en) Cephalosporin compounds
GB2005246A (en) beta -Lactam compounds and processes for their preparation
SE7612963L (sv) Tienamycinderivat
FR2435481B1 (sv)
GB1490649A (en) Hexitol derivatives
SE7707366L (sv) Forfarande for framstellning av 7alfa-metoxi-cefalosporansyraderivat
ES449209A1 (es) Procedimiento de preparacion de derivados pentaciclicos.
ES8207218A1 (es) Un procedimiento para la preparacion de un antibiotico macrolida.
ES421130A1 (es) Procedimiento para preparar derivados de ditiino (1,4) (2, 3-c) pirrol.
ES457370A1 (es) Procedimiento de preparacion de nuevos derivados del nafta- leno.
SE7709646L (sv) Antibakteriella medel
ATE18560T1 (de) Cephemderivate und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7612960-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7612960-0

Format of ref document f/p: F